Cover Stories

Fully Automated OCT Analysis of Eyes Healing From Macular Hole Surgery

A biomedical data science approach reveals how preoperative SD-OCT scans can help surgeons prepare for macular hole repair.

Theodore Leng, MD, MS

Gene Therapy: The Next Frontier for Treatment of Acquired and Inherited Ocular Disorders

These cutting-edge approaches may soon successfully treat some forms of retinal diseases previously thought to be untreatable.

Carly Seidman, MD, and Szilá,rd Kiss, MD

Endoscopy and Its Potential for Visualization

Thanks to recent advances, this technology can be complementary to microscope viewing.

Jeffrey S. Heier, MD

Individualizing Therapy for DME

Disease features as well as individual patient needs and preferences should drive treatment choices.

Antonio Capone Jr, MD

Early Detection of Choroidal Neovascularization Using Home Monitoring

Raising the standard for at-home monitoring can help us help our patients save their vision.

Allen C. Ho, MD

What Is New with Anti-VEGF Therapy for DME

A wealth of evidence supports anti-VEGF therapy in DME.

Dilsher S. Dhoot, MD, and Dante Pieramici, MD

Gene Therapy for Treatment of Retinal Disease

Lauren S. Taney, MD, and Elias Reichel, MD

Techniques in Retinal Surgery: Maybe Controversial, Maybe Not

A review of surgical techniques to enhance patients' visual outcomes after vitrectomy.

Kourous A. Rezaei, MD

Application of Molecular Genomics in Radiation-Sparing Therapy

Pars plana vitrectomy, membrane peel, endolaser ablation, and transvitreal biopsy in the primary management of uveal malignant melanoma.

Victor M. Villegas, MD; S.K. Steven Houston III, MD; Aaron Gold, OD; Andrea Wildner, CRA; Fiona Ehlies, CDOS; Jennifer Thomson, CRA; Azeema Latiff, BSN, MBA; and Timothy G. Murray, MD, MBA

Widefield Imaging: A Review of Current Technology

Rishi P. Singh, MD; Giovanni Staurenghi, MD; Richard Rosen, MD, and Patricia Garcia, MD

A Peek Down the Pipeline: Emerging Drug Delivery Options for Retinal Disease

Steven Yeh, MD; Thomas A. Albini, MD; and Andrew A. Moshfeghi, MD, MBA

Anti-VEGF Maintenance Therapy for Neovascular AMD

Several protocols to reduce the treatment burden associated with intravitreal anti-VEGF injections are under investigation.

Carl D. Regillo, MD

Status of Sustained-release Steroids for Diabetic Macular Edema

With David S. Boyer, MD

Seeing the Future With Telemedicine

With Darius M. Moshfeghi, MD

Controversies in Vitreoretinal Surgery: Is Scleral Buckling an Important Mainstay in the Treatment of Retinal Detachment in 2014?

Gaurav K. Shah, MD; Baseer Ahmad, MD; and Szilárd Kiss, MD

Evaluating Age-related Macular Degeneration With Ultra-widefield Fundus Autofluorescence

Patterns in the periphery may offer prognostic clues regarding progression.

SriniVas R. Sadda, MD

Suprachoroidal Steroid Delivery

Enforcing our management for refractory macular edema.

Ehab N. El Rayes, MD, PhD

Developments in Therapy for Neovascular AMD

Treatments on the horizon move beyond the paradigm of monthly anti-VEGF therapy.

Pravin U. Dugel, MD

Management of Refractory DME

The posterior hyaloid is the beginning of the decision-making process.

Tarek S. Hassan, MD

The Microplasmin for Pediatric Vitrectomy Study

Ocriplasmin has been evaluated in children in a phase 2 trial; results have not been announced.

Kimberly Drenser, MD, PhD